Market Size (2016)
2016
$61.52B
Vertical: HealthcareBase Year: 201812 Sections
Market Size (2016)
2016
$61.52B
Projected (2025)
2025
$106.06B
CAGR (2016–2025)
6.2%
6.2%Key Players
109+
The anti-ageing drugs market is driven by various factors such as increase in elderly population worldwide, increasing number of medical tourisms for cosmetic procedures, and rising consumer demand for anti-ageing products. Moreover, with the growing consciousness among the youth regarding beauty, there is a potential market for anti-ageing drugs
The Anti ageing Drugs Market market is projected to grow at a CAGR of 6.2% from 2016 to 2025.
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansAnti-aging is the process of slowing down or reverse the processes of aging. Anti-ageing drugs are used to improve or possibly delay the ageing process. The progress of the global anti-ageing drugs market is largely propelled by the increasing awareness regarding age-related problems and growing anxieties about looks and appearance among the youth across the globe. The development in medical science and innovation of new anti-aging drugs are some of the key factors which are projected to boost the growth of anti-ageing drugs market over the forecast period
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2018
Historical Period
2016 – 2018
Forecast Period
2018 – 2025
Primary Interviews
150+
Historical data (2016–2018) and forecast period (2018–2025)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThreat of New Entrants
The threat of new entrants is moderate in the global anti-ageing drugs market due to the development of the potential market. This market is characterized by a reasonable degree of brand loyalty, where establishing a brand name is difficult for new entrants. The rising awareness regarding the anti-ageing products among the patient pool pushes the currently established and other manufacturers to focus more on developing products with the incorporation of innovation. There is a stronghold of few big companies in this market, which can make the entry of the new players challenging. Thus, the threat of new entrants in the market is moderate.
Bargaining Power of Suppliers
In the global anti-ageing drugs industry, suppliers are product manufacturers. The existing key companies capture a significant share of the market and have the capability of influencing the cost of the products. Another factor affecting the bargaining power of suppliers is the switching cost for buyers. Furthermore, many companies are focused on entering the developing economies, which increases competition in the market. Therefore, the overall bargaining power of suppliers in the global anti-ageing drugs market is moderate.
Threat of Substitutes
The threat of substitutes in the global anti-ageing drugs market is moderate to high. Substitutes pose a moderate to high threat in the global anti-ageing drugs market due to the availability of different types of similar products by the key market players. However, quality and trust issues for the products provided by the new players, and excellent service provided by the existing players may restrict the threat by the substitutes to an extent.
Bargaining Power of Buyers
The bargaining power of buyers is moderate in the global anti-ageing drugs market. The presence of buyers in the market is growing due to the increasing awareness about the different products, along with the rising inclination of people towards the use of anti-ageing products. Also, some buyers are price and brand sensitive and might prefer particular products from certain companies, thereby moderately affecting their bargaining power in the market.
Intensity of Rivalry
The degree of competition in the global anti-ageing drugs market is moderate to high. The moderate degree of product differentiation among existing players increases the intensity of rivalry in the market. Companies involved in the global anti-ageing drugs industry are trying to develop different types of products to make differentiation more affordable. To overcome the competition, players are engaged in developing a process to lower their manufacturing costs. Moreover, the players are also developing advanced techniques for differentiating their product from their rivals.
Market estimates by geography (2025)
InsightNorth America leads with $32.53B by 2025, while Asia Pacific is projected to grow fastest at a 6.9% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2016 | 2018 | 2025 | CAGR | SHARE |
|---|---|---|---|---|---|
| Middle East and Africa | $5.15B | $6.27B | $7.76B | 4.7% | 7% |
| North America | $18.46B | $25.30B | $32.53B | 6.5% | 31% |
| Asia Pacific | $15.20B | $21.10B | $27.78B | 6.9% | 27% |
| Europe | $17.30B | $23.70B | $30.69B | 6.6% | 30% |
| South America | $3.38B | $4.27B | $5.27B | 5.0% | 5% |
| Total | $59.50B | $80.64B | $104.04B | 6.2% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$104.04B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Serums | $39.65B | 6.2% | 53% |
| Supplement Products | $27.47B | 6.2% | 47% |
| Stem Cell Products | $20.39B | 6.2% | 77% |
| Others | $16.53B | 6.2% | 53% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Anti ageing Drugs Market covering market dynamics, competitive landscape, and strategic outlook.
The Anti ageing Drugs Market market is projected to reach $106.06B by 2025, growing at 6.2% CAGR. The Serums segment holds the largest share.
The anti-ageing drugs market is driven by various factors such as increase in the elderly population worldwide, increasing number of medical tourism for cosmetic procedures, and rising consumer demand for anti-ageing products. Moreover, these factors have led to the introduction of safe and efficient anti-ageing products and services in the market. With the growing consciousness among the youth regarding beauty, there is a potential market for anti-ageing drugs and aesthetic plastic surgeries
Increasing geriatric population is likely to positively affect market growth. According to the Population Reference Bureau in 2016, the number of Americans aged 65 and older is projected to reach 98 million by 2060.
Similarly, according to the United Nations, around 857,040 older population is expected to reside in Asia by 2050. According to the World Population Ageing Report, in 2018, globally there were an estimated 962 million people aged 60 or over, which is 13% of the total global population. Furthermore, it was found that the anti-ageing drugs market is directly proportional to the growing population as their skin loses fluid collagen, which results in the development of wrinkles near the neck and face area. This results in the demand for anti-ageing drugs and indirectly the growth of the market.
Since many years, the global population was majorly focusing on minimally invasive procedures to treat variety of medical and aesthetic imperfections such as scars, wrinkles, skin discolorations, unwanted spots, excess fat, spider veins, etc. Increasing awareness about benefits of combination therapies in aesthetic medicines is also leading to its widespread acceptance among the population of all age groups.
As indicated by the World Population Report 2015 published by the United Nations, the worldwide population is ageing at the rate of 1.18% per annum. Every year, around 83 million individuals are reaching the age group of more than 60 years. Furthermore, the increasing interest among the youth for less painful treatment is making them choose anti-ageing drugs thus driving the growth of the market.
The anti-ageing drugs market is currently in the developmental stage, and scepticism is the most critical market restraint. The term anti-ageing medicine has negative connotations and suffers from a lack of clear definition. As many nutritional products with dubious claims are easily available on the web, there has occurred a flood of self-proclaimed experts proposing growth hormones, skin-care products, beta-glucan, and a variety of dietary and nutritional supplements with claims that are difficult to validate. This concern has been expressed in many citizen bodies and media. MitoQ, resveratrol, and pterostilbene are some dietary supplements that have also been studied in this context.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 109 companies operating in the Anti ageing Drugs Market market, including revenue, employee count, and market positioning where available.
Showing 109 of 109 companies
Nuxe Laboratory
Company Headquarters: Paris, France Founded: 1989 Company Working: Nuxe Laboratory develops and manufactures dermo-cosmetic products. The company offers a range of moisturizers, masks, scrubs, sun protection lotions, hand and nail creams, makeup removers, shower gels, oils, compact powders, lip balms, shaving gels, and deodorants, among others. It has its research laboratory and factory in France, where it can express all its expertise to create effective and ultra-sensorial face and body care products based on patented botanical active ingredients. One of the brands of the company is Resultime, an expert anti-ageing skincare brand underpinned by a patented technological innovation, vectorized micro-collagen.
DermaFix
Company Headquarters: Johannesburg, South Africa Founded: 2004 Company Working: DermaFix has sourced laboratories across the world to supply the finest and most effective skin care products. The company manufactures dermatologically approved products with visible results, formulated for the correction, prevention, and protection of the skin. One of the company’s flagship products is DermaFix DeCeleRate, which contains three smart anti-ageing peptides that have been tried and tested for over nine years. This DeCeLeRate formulation incorporates peptides, such as Matrixyl synthe’6, Matrixyl, Matrixyl 3000, and Matrixyl synthe’6, which assist in boosting and rebuilding the skin whilst improving wrinkle depth.
Elysium Health
Company Headquarters: New York, US Founded: 2014 Company Working: Elysium Health is a life sciences company developing clinically-validated health products based on ageing research. The company is guided by a Scientific Advisory Board, which includes multiple winners of the Nobel Prize, as well as researchers and doctors who are experts in chemistry, physiology, neuroscience, complex chemical systems, biochemistry, and many other fields of study. The company has been best known for its cellular health supplement, BASIS. In September 2019, Elysium Health announced the acceptance of an Investigational New Drug ("IND") application by the Food and Drug Administration (FDA) to evaluate the efficacy of BASIS for the prevention of acute kidney injury (AKI) in surgical cardiac patients.
Estée Lauder Inc.
Company Headquarters: New York, US Founded: 1946 Workforce: ~46,000 Company Working: Estée Lauder Inc. offers skincare, makeup, and fragrance products. The company has brands, namely, AERIN, Aramis, Aveda, BECCA, Bobbi Brown, Bumble and bumble, By Kilian, Clinique, Darphin, Donna Karan New York, DKNY, Editions de Parfums Frédéric Malle, Ermenegildo Zegna, Estée Lauder, GLAMGLOW, Jo Malone London, Kiton, La Mer, Lab Series, Le Labo, M•A•C, Michael Kors, Origins, Prescriptives, RODIN olio Lusso, Smashbox, Tom Ford, Tommy Hilfiger, Too Faced and Tory Burch. Its products are sold in more than 135 countries and territories.
L’Oréal
Company Headquarters: Clichy, France Founded: 1909 Workforce: ~82,600 Company Working: L’Oréal manufactures and markets cosmetic products. The company’s thirty-four international brands include Kiehl’s, Lancôme, Giorgio Armani Beauty, Yves Saint Laurent Beauté, Ralph Lauren, Clarisonic, Maybelline New York, Essie, Kérastase, Biotherm, Shu Uemura, Viktor&Rolf, Maison Martin Margiela, Urban Decay, Redken, Vichy, La Roche-Posay, Diesel, Garnier, L’Oréal Paris, and many others. One of the brands, La Roche-Posay’s products are currently recommended by 90,000 dermatologists worldwide and sold in over 50 countries. The research team of the company has registered 498 patents to date.
Private Label Sk.In
Company Headquarters: Florida, US Founded: 2012 Workforce: ~200 Company Working: Private Label Sk.In manufactures, packages, and markets skin care products. Apart from that, the company also offers a wide range of solutions for businesses looking for contract manufacturing, custom formulation, white labeling services, and a variety of other services.
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Anti ageing Drugs Market